Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

2
results for

"Mee Yon Cho"

Article category

Keywords

Publication year

"Mee Yon Cho"

Case Report

Hepatic involvement of systemic disease

Three cases of glycogenic hepatopathy mimicking acute and relapsing hepatitis in type I diabetes mellitus
Jae Hwang Cha, Sang Ho Ra, Yu Mi Park, Yong Kwan Ji, Ji Hyun Lee, So Yeon Park, Soon Koo Baik, Sang Ok Kwon, Mee Yon Cho, Moon Young Kim
Clin Mol Hepatol 2013;19(4):421-425.
Published online December 28, 2013
DOI: https://doi.org/10.3350/cmh.2013.19.4.421

Glycogenic hepatopathy (GH) is an uncommon cause of serum transaminase elevation in type I diabetes mellitus (DM). The clinical signs and symptoms of GH are nonspecific, and include abdominal discomfort, mild hepatomegaly, and transaminase elevation. In this report we describe three cases of patients presenting serum transaminase elevation and hepatomegaly with a history of poorly controlled type I DM. All of the cases showed sudden elevation of transaminase to more than 30 times the upper normal range (like in acute hepatitis) followed by sustained fluctuation (like in relapsing hepatitis). However, the patients did not show any symptom or sign of acute hepatitis. We therefore performed a liver biopsy to confirm the cause of liver enzyme elevation, which revealed GH. Clinicians should be aware of GH so as to prevent diagnostic delay and misdiagnosis, and have sufficient insight into GH; this will be aided by the present report of three cases along with a literature review.

Citations

Citations to this article as recorded by  Crossref logo
  • Transaminases in the Thousands: Glycogenic Hepatopathy Mimicking Acute Hepatitis
    CP Ganesh, Naveen Bhagat, Dipanwita Biswas, Suvradeep Mitra, Shagun Singh, Arka De, Sunil Taneja, Ajay Duseja
    Journal of Clinical and Experimental Hepatology.2026; 16(3): 103476.     CrossRef
  • Improvement of Glycogenic Hepatopathy With Minimal Corresponding Improvement of Glycemic Control in a Person With Type 1 Diabetes: Case Report and Literature Review
    Joselyn Tessa Tonleu, Nicolas A. Reyes, Natalie D. Hillerson, William B. Horton
    AACE Clinical Case Reports.2025; 11(2): 113.     CrossRef
  • Expanding the Differential Diagnosis: Severe, Swollen Hepatocytes in a Patient With ALT Above 1000 U/L
    Michael Eller, Lindsey Westbrook, Avash Kalra
    Gastroenterology.2025; 168(6): 1062.     CrossRef
  • Hepatomegaly and Deranged Liver Enzymes in a Patient With Poorly Controlled Type 1 Diabetes Mellitus
    George I Habeos, Dimitris Ziazias, Christina Petropoulou, Georgios Eleftherakis, Georgios K Markantes
    JCEM Case Reports.2025;[Epub]     CrossRef
  • Glycogenic Hepatopathy: A Case Report of a Rare Complication in Uncontrolled Diabetes
    Mais Musleh, Amani AlMokbel
    Clinical Case Reports.2025;[Epub]     CrossRef
  • Glycogenic hepatopathy is associated with type 1 diabetes mellitus in only a minority of cases in a contemporary adult population
    Brian K. Cox, Maha Guindi, Danielle Hutchings, Stacey A. Kim, Kevin M. Waters, Brent K. Larson
    Annals of Diagnostic Pathology.2023; 64: 152130.     CrossRef
  • A Case of Glycogenic Hepatopathy as a Complication of Poorly Controlled Type 1 Diabetes Mellitus
    Samhitha Munugoti, Vamsee Reddy, Gaurav Patel, Maneesh Gaddam, Triveni Abburi, Osamu Isozaki
    Case Reports in Endocrinology.2022; 2022: 1.     CrossRef
  • Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy
    Jonathan Mertens, Christophe De Block, Maarten Spinhoven, Ann Driessen, Sven M. Francque, Wilhelmus J. Kwanten
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • Liver chemistries in glycogenic hepatopathy associated with type 1 diabetes mellitus: A systematic review and pooled analysis
    Samir Haffar, Manhal Izzy, Hany Habib, Takaaki Sugihara, Darrick K. Li, Ayush Sharma, Zhen Wang, M. Hassan Murad, Kymberly D. Watt, Fateh Bazerbachi
    Liver International.2021; 41(7): 1545.     CrossRef
  • Glycogen Hepatopathy: A Reversible yet Relapsing Cause of Hepatitis in Type 1 Diabetics
    Mishah Azhar, Muhammad Hammami, Ahmad Musmar, Matthew Bromer
    Cureus.2021;[Epub]     CrossRef
  • Glycogenic hepatopathy in children with poorly controlled type 1 diabetes mellitus
    Nor Azizah Abu, Chooi Bee Lim, Noor Shafina Mohd Nor
    Clinical Pediatric Endocrinology.2021; 30(2): 93.     CrossRef
  • Hepatocellular Glycogen Accumulation in the Setting of Poorly Controlled Type 1 Diabetes Mellitus: Case Report and Review of the Literature
    Atinuke Aluko, Ikponmwosa Enofe, Jacob Burch, Julie Yam, Nazia Khan
    Case Reports in Hepatology.2020; 2020: 1.     CrossRef
  • Glycogenic Hepatopathy: A Rare Hepatic Complication of Poorly Controlled Type 1 DM
    Leila A. Alenazy, Muhammad Javed, Hussien Elsiesy, Emad Raddaoui, Waleed K. Al-Hamoudi
    Case Reports in Medicine.2020; 2020: 1.     CrossRef
  • Hepatomegaly and type 1 diabetes: a clinical case of Mauriac’s syndrome
    Fortunato Lombardo, Stefano Passanisi, Albino Gasbarro, Giovanni Tuccari, Antonio Ieni, Giuseppina Salzano
    Italian Journal of Pediatrics.2019;[Epub]     CrossRef
  • Glycogenic hepatopathy as an unusual etiology of deranged liver function in a patient with type 1 diabetes
    David TW Lui, Yu-Cho Woo, Wing-Sun Chow, Chi-Ho Lee, Alan CH Lee, Eunice KH Leung, Kathryn CB Tan, Karen SL Lam, Joanne KY Lam
    Medicine.2019; 98(17): e15296.     CrossRef
  • Mauriac syndrome: An unusual presentation with portal fibrosis
    Mouna Medhioub, Hend Ayedi, Emna Chelbi, Amal Khsiba, Lamine Hamzaoui, Mohamed Moussadek Azzouz
    La Presse Médicale.2019; 48(6): 718.     CrossRef
  • Glycogenic Hepatopathy
    Bashar Sharma, Marsha Antoine, Mili Shah, Rochelle Nagales Nagamos, Savio John
    ACG Case Reports Journal.2019; 6(7): e00115.     CrossRef
  • Glycogenic Hepatopathy in Type 1 Diabetes Mellitus
    Shohei Asada, Hideto Kawaratani, Tsuyoshi Mashitani, Daisuke Kaya, Maiko Nishigori, Takuya Kubo, Yasuhiko Sawada, Yukihisa Fujinaga, Kosuke Kaji, Mitsuteru Kitade, Tadashi Namisaki, Kei Moriya, Akira Mitoro, Hitoshi Yoshiji
    Internal Medicine.2018; 57(8): 1087.     CrossRef
  • Focal Hepatic Glycogenosis in a Patient With Uncontrolled Diabetes Mellitus Type 1
    Tetiana Glushko, Sergiy V. Kushchayev, Dmitry Trifanov, Aliaksei Salei, Diego Morales, Gerard Berry, Justin Mackey, Oleg M. Teytelboym
    Journal of Computer Assisted Tomography.2018; 42(2): 230.     CrossRef
  • Glycogenic hepatopathy
    Johad Khoury, Yaniv Zohar, Naim Shehadeh, Tarek Saadi
    Hepatobiliary & Pancreatic Diseases International.2018; 17(2): 113.     CrossRef
  • Glycogenic hepatopathy: A narrative review
    Jagannath M Sherigar, Joline De Castro, Yong Mei Yin, Debra Guss, Smruti R Mohanty
    World Journal of Hepatology.2018; 10(2): 172.     CrossRef
  • Glycogen Hepatopathy: A Rare and Underrecognized Cause of Recurrent Transaminitis in Patients with Uncontrolled Type 2 Diabetes Mellitus
    Kishore Kumar, Shehriyar Mehershahi, Chukwunonso Chime, Hassan Tariq, Suresh Kumar Nayudu, Sridhar Chilimuri
    Case Reports in Gastroenterology.2018; 12(2): 466.     CrossRef
  • Four cases of type 1 diabetes mellitus showing sharp serum transaminase increases and hepatomegaly due to glycogenic hepatopathy
    Yuichi Ikarashi, Tomomi Kogiso, Etsuko Hashimoto, Kuniko Yamamoto, Kazuhisa Kodama, Makiko Taniai, Nobuyuki Torii, Hiroko Takaike, Yasuko Uchigata, Katsutoshi Tokushige
    Hepatology Research.2017;[Epub]     CrossRef
  • Glycogenic Hepatopathy: Resolution with Minimal Glucose Control
    Abhimanyu Chandel, Brittany Scarpato, Jeanette Camacho, Miles McFarland, Shaffer Mok
    Case Reports in Hepatology.2017; 2017: 1.     CrossRef
  • Glycogenic hepatopathy in young adults: a case series
    Marco Silva, Margarida Marques, Hélder Cardoso, Susana Rodrigues, Patrícia Andrade, Armando Peixoto, Joana Pardal, Joanne Lopes, Fátima Carneiro, Guilherme Macedo
    Revista Española de Enfermedades Digestivas.2016;[Epub]     CrossRef
  • Glycogenic Hepatopathy: Thinking Outside the Box
    Nishant Parmar, Muslim Atiq, Lee Austin, Ross A. Miller, Thomas Smyrk, Kabir Ahmed
    Case Reports in Gastroenterology.2015; 9(2): 221.     CrossRef
  • Glycogenic hepatopathy in a Korean girl with poorly controlled type 1 diabetes mellitus
    Hwal Rim Jeong, Young Seok Shim, Young Bae Kim, Hae Sang Lee, Jin Soon Hwang
    Annals of Pediatric Endocrinology & Metabolism.2014; 19(1): 49.     CrossRef
  • 13,497 View
  • 87 Download
  • Crossref
Original Article

Liver fibrosis, cirrhosis, and portal hypertension

Ultrasonographic scoring system score versus liver stiffness measurement in prediction of cirrhosis
Kyoung Min Moon, Gaeun Kim, Soon Koo Baik, Eunhee Choi, Moon Young Kim, Hyoun A Kim, Mee Yon Cho, Seung Yong Shin, Jung Min Kim, Hong Jun Park, Sang Ok Kwon, Young Woo Eom
Clin Mol Hepatol 2013;19(4):389-398.
Published online December 28, 2013
DOI: https://doi.org/10.3350/cmh.2013.19.4.389
Background/Aims

We compared the cirrhosis-prediction accuracy of an ultrasonographic scoring system (USSS) combining six representative sonographic indices with that of liver stiffness measurement (LSM) by transient elastography, and prospectively investigated the correlation between the USSS score and LSM in predicting cirrhosis.

Methods

Two hundred and thirty patients with chronic liver diseases (187 men, 43 women; age, 50.4±9.5 y, mean±SD) were enrolled in this prospective study. The USSS produces a combined score for nodularity of the liver surface and edge, parenchyma echogenicity, presence of right-lobe atrophy, spleen size, splenic vein diameter, and abnormality of the hepatic vein waveform. The correlations of the USSS score and LSM with that of a pathological liver biopsy (METAVIR scoring system: F0-F4) were evaluated.

Results

The mean USSS score and LSM were 7.2 and 38.0 kPa, respectively, in patients with histologically overt cirrhosis (F4, P=0.017) and 4.3 and 22.1 kPa in patients with fibrotic change without overt cirrhosis (F0-F3) (P=0.025). The areas under the receiver operating characteristic (ROC) curves of the USSS score and LSM for F4 patients were 0.849 and 0.729, respectively. On the basis of ROC curves, criteria of USSS ≥6: LSM ≥17.4 had a sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 89.2%:77.6%, 69.4%:61.4%, 86.5%:83.7%, 74.6%:51.9% and 0.83:0.73, respectively, in predicting F4.

Conclusions

The results indicate that this USSS has comparable efficacy to LSM in the diagnosis of cirrhosis.

Citations

Citations to this article as recorded by  Crossref logo
  • Sonographic Patterns and Findings Within the Liver Among Hepatitis B and C Patients: A Cross-Sectional Study
    Florien Ujemurwego, Racheal Ankunda, Gaspard Harerimana, Placide Bikorimana, Josiane Uwineza, Jean de Dieu Niyonteze
    Journal of Diagnostic Medical Sonography.2026;[Epub]     CrossRef
  • Bile acid profiles in adult patients with biliary atresia who achieve native liver survival after portoenterostomy
    Masahiro Takeda, Hajime Takei, Mitsuyoshi Suzuki, Takafumi Tsukui, Koichi Tsuboi, Hiroko Watayo, Takanori Ochi, Hiroyuki Koga, Hiroshi Nittono, Atsuyuki Yamataka
    Scientific Reports.2024;[Epub]     CrossRef
  • Direct-Acting Antivirals Reduce the De Novo Development of Esophageal Varices in Patients with Hepatitis C Virus Related Liver Cirrhosis
    Yung-Yu Hsieh, Wei-Ming Chen, Kao-Chi Chang, Te-Sheng Chang, Chao-Hung Hung, Yao-Hsu Yang, Shui-Yi Tung, Kuo-Liang Wei, Chen-Heng Shen, Cheng-Shyong Wu, Yuan-Jie Ding, Jing-Hong Hu, Yu-Ting Huang, Meng-Hung Lin, Chung-Kuang Lu, Yi-Hsiung Lin, Ming-Shyan L
    Viruses.2023; 15(1): 252.     CrossRef
  • Reproducibility and diagnostic accuracy of pocket-sized ultrasound devices in ruling out compensated cirrhosis of mixed etiology
    Andrea Costantino, Alessandra Piagnani, Nicoletta Nandi, Valentina Sciola, Marco Maggioni, Francesca Donato, Maurizio Vecchi, Pietro Lampertico, Giovanni Casazza, Mirella Fraquelli
    European Radiology.2022; 32(7): 4609.     CrossRef
  • Application of ultrasound for the diagnosis of cirrhosis/portal hypertension
    Seul Ki Han, Moon Young Kim, Seong Hee Kang, Soon Koo Baik
    Journal of Medical Ultrasonics.2022; 49(3): 321.     CrossRef
  • Video-assisted liver ultrasound training for non-radiologists: protocol and preliminary results
    Sureeporn Jangsirikul, Surachate Siripongsakun, Roongruedee Chaiteerakij
    HPB.2021; 23(6): 962.     CrossRef
  • Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use
    Daniel Fuster, Xavier García-Calvo, Paola Zuluaga, Ferran Bolao, Robert Muga
    World Journal of Gastroenterology.2021; 27(23): 3223.     CrossRef
  • Noninvasive Assessment of Hepatitis C Virus Infected Patients Using Vibration-Controlled Transient Elastography
    Mira Florea, Teodora Serban, George Razvan Tirpe, Alexandru Tirpe, Monica Lupsor-Platon
    Journal of Clinical Medicine.2021; 10(12): 2575.     CrossRef
  • Combination of FIB-4 with ultrasound surface nodularity or elastography as predictors of histologic advanced liver fibrosis in chronic liver disease
    Maryam Moini, Fernanda Onofrio, Bettina E. Hansen, Oyedele Adeyi, Korosh Khalili, Keyur Patel
    Scientific Reports.2021;[Epub]     CrossRef
  • ANGPTL4 regulates CD163 expression and Kuppfer cell polarization induced cirrhosis via TLR4/NF-κB pathway
    Xin Zhang, Shanshan Yuan, Xin Zhang, Tao Zhang, Cunying Meng, Kun Zhuang, Shuangsuo Dang
    Experimental Cell Research.2021; 405(2): 112706.     CrossRef
  • Combining hepatic surface nodularity and serum tests better predicts hepatic fibrosis stages in chronic liver disease
    Hyo Jung Cho, Jaewon Choi, Bohyun Kim, JeongGil Ko, Joon-Il Choi, Jimi Huh, Jei Hee Lee, Jai Keun Kim
    Abdominal Radiology.2021; 46(9): 4189.     CrossRef
  • Ultrasonographic grayscale findings related to fibrosis in patients with non-alcoholic fatty liver disease: comparison with transient elastography and Fib-4 index
    Naoki Matsumoto, Mariko Kumagawa, Masahiro Ogawa, Masahiro Kaneko, Yukinobu Watanabe, Hiroshi Nakagawara, Ryota Masuzaki, Tatsuo Kanda, Mitsuhiko Moriyama, Masahiko Sugitani
    Journal of Medical Ultrasonics.2021; 48(3): 323.     CrossRef
  • Severity of Fontan-Associated Liver Disease Correlates with Fontan Hemodynamics
    Anastasia Schleiger, Madeleine Salzmann, Peter Kramer, Friederike Danne, Stephan Schubert, Christian Bassir, Tobias Müller, Hans-Peter Müller, Felix Berger, Stanislav Ovroutski
    Pediatric Cardiology.2020; 41(4): 736.     CrossRef
  • Ultrasonographic morphological diagnosis of chronic liver disease: 2-dimensional shear wave elastography as an add-on test
    Young Seo Cho, Woo Kyoung Jeong, Yongsoo Kim
    Ultrasonography.2020; 39(3): 272.     CrossRef
  • Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir
    Tae Seop Lim, Hyun Woong Lee, Jung Il Lee, In Hee Kim, Chang Hun Lee, Byoung Kuk Jang, Woo Jin Chung, Hyung Joon Yim, Sang Jun Suh, Yeon Seok Seo, Han Ah Lee, Jung Hwan Yu, Jin‐Woo Lee, Sang Gyune Kim, Young Seok Kim, Soo Young Park, Won Young Tak, Soon S
    Journal of Viral Hepatitis.2020; 27(10): 1052.     CrossRef
  • Staging of Liver Fibrosis by Means of Semiautomatic Measurement of Liver Surface Nodularity in MRI
    Seong Woo Kim, Youe Ree Kim, Keum Ha Choi, Eun Young Cho, Ji Soo Song, Ji-Eon Kim, Tae-Hoon Kim, Young Hwan Lee, Kwon-Ha Yoon
    American Journal of Roentgenology.2020; 215(3): 624.     CrossRef
  • Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis
    Kyeong-Ah Kwak, Hyun-Jae Cho, Jin-Young Yang, Young-Seok Park
    Canadian Journal of Gastroenterology and Hepatology.2018; 2018: 1.     CrossRef
  • Precision analysis of a quantitative CT liver surface nodularity score
    Andrew Smith, Elliot Varney, Kevin Zand, Tara Lewis, Reza Sirous, James York, Edward Florez, Asser Abou Elkassem, Candace M. Howard-Claudio, Manohar Roda, Ellen Parker, Eduardo Scortegagna, David Joyner, David Sandlin, Ashley Newsome, Parker Brewster, Set
    Abdominal Radiology.2018; 43(12): 3307.     CrossRef
  • Ultrasound findings of liver damage in a series of patients consecutively admitted for treatment of alcohol use disorder
    Daniel Fuster, Xavier Garcia-Calvo, Paola Zuluaga, Inmaculada Rivas, Arantza Sanvisens, Jordi Tor, Robert Muga
    Drug and Alcohol Dependence.2018; 190: 195.     CrossRef
  • Liver Surface Nodularity Score Allows Prediction of Cirrhosis Decompensation and Death
    Andrew D. Smith, Kevin A. Zand, Edward Florez, Reza Sirous, Darya Shlapak, Frederico Souza, Manohar Roda, Jason Bryan, Amit Vasanji, Michael Griswold, Seth T. Lirette
    Radiology.2017; 283(3): 711.     CrossRef
  • 2D Shear Wave Elastography of Liver in Patients with Primary Extrahepatic Portal Vein Obstruction
    Kumble S. Madhusudhan, Raju Sharma, Ragini Kilambi, Sudhin Shylendran, Shalimar, Peush Sahni, Arun K. Gupta
    Journal of Clinical and Experimental Hepatology.2017; 7(1): 23.     CrossRef
  • Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with Contrast-Enhanced Ultrasonography for Cirrhosis: A Systematic Review and Meta-Analysis
    Gaeun Kim, Kwang Yong Shim, Soon Koo Baik
    Gut and Liver.2017; 11(1): 93.     CrossRef
  • An endoplasmic reticulum protein, Nogo‐B, facilitates alcoholic liver disease through regulation of kupffer cell polarization
    Jin‐Kyu Park, Mingjie Shao, Moon Young Kim, Soon Koo Baik, Mee Yon Cho, Teruo Utsumi, Ayano Satoh, Xinsho Ouyang, Chuhan Chung, Yasuko Iwakiri
    Hepatology.2017; 65(5): 1720.     CrossRef
  • Therapeutic Effect and Location of GFP-Labeled Placental Mesenchymal Stem Cells on Hepatic Fibrosis in Rats
    Jiong Yu, Guangshu Hao, Dan Wang, Jingqi Liu, Xiaotian Dong, Yanni Sun, Qiaoling Pan, Yang Li, Xiaowei Shi, Lanjuan Li, Hongcui Cao
    Stem Cells International.2017; 2017: 1.     CrossRef
  • FIB-4 Score as a Useful Screening Test for Diagnosing Liver Fibrosis
    Kwangjin Ahn, Juwon Kim, Yoonjung Kim, Young Uh, Kap Jun Yoon
    Journal of Laboratory Medicine and Quality Assurance.2017; 39(1): 16.     CrossRef
  • The need for histological subclassification of cirrhosis: a systematic review and meta‐analysis
    Gaeun Kim, Samuel S. Lee, Soon Koo Baik, Youn Zoo Cho, Moon Young Kim, Sang Ok Kwon, Seung Hwan Cha, Mee Yon Cho
    Liver International.2016; 36(6): 847.     CrossRef
  • Liver Surface Nodularity Quantification from Routine CT Images as a Biomarker for Detection and Evaluation of Cirrhosis
    Andrew D. Smith, Cody R. Branch, Kevin Zand, Charu Subramony, Haowei Zhang, Katherine Thaggard, Richard Hosch, Jason Bryan, Amit Vasanji, Michael Griswold, Xu Zhang
    Radiology.2016; 280(3): 771.     CrossRef
  • Differential Diagnosis of Diffuse Liver Disease
    Soon Koo Baik
    Clinical Ultrasound.2016; 1(1): 1.     CrossRef
  • Usefulness of Ultrasonographic Scoring System in Diagnosis of Alcoholic Cirrhosis
    Kyoung Min Moon, Soon Koo Baik
    Clinical Ultrasound.2016; 1(2): 92.     CrossRef
  • Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver disease
    Fernando Ezquer
    World Journal of Gastroenterology.2016; 22(1): 24.     CrossRef
  • Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease
    Chavdar S Pavlov, Giovanni Casazza, Marianna Semenistaia, Dimitrinka Nikolova, Emmanuel Tsochatzis, Ekaterina Liusina, Vladimir T Ivashkin, Christian Gluud
    Cochrane Database of Systematic Reviews.2016;[Epub]     CrossRef
  • Mesenchymal stem cell therapy for liver fibrosis
    Young Woo Eom, Kwang Yong Shim, Soon Koo Baik
    The Korean Journal of Internal Medicine.2015; 30(5): 580.     CrossRef
  • The Accuracy of Ultrasonography for the Evaluation of Portal Hypertension in Patients with Cirrhosis: A Systematic Review
    Gaeun Kim, Youn Zoo Cho, Soon Koo Baik, Moon Young Kim, Won Ki Hong, Sang Ok Kwon
    Korean Journal of Radiology.2015; 16(2): 314.     CrossRef
  • Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives
    Young Woo Eom
    World Journal of Gastroenterology.2015; 21(36): 10253.     CrossRef
  • Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model
    Yoon Ok Jang, Moon Young Kim, Mee Yon Cho, Soon Koo Baik, Youn Zoo Cho, Sang Ok Kwon
    BMC Gastroenterology.2014;[Epub]     CrossRef
  • 15,469 View
  • 98 Download
  • Crossref